Journal of Cardiovascular Surgery最新文献

{"title":"Preliminary experience with new generation balloon expandable stent-graft in the treatment of innominate artery obstructive disease.","authors":"Michele Antonello,&nbsp;Andrea Xodo,&nbsp;Francesco Squizzato,&nbsp;Marco Zavatta,&nbsp;Carlo Maturi,&nbsp;Michele Piazza","doi":"10.23736/S0021-9509.22.12158-0","DOIUrl":"https://doi.org/10.23736/S0021-9509.22.12158-0","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to describe a single center preliminary experience with the use of a specific balloon expandable stent-graft for the treatment of innominate artery (IA) obstructive lesions.</p><p><strong>Methods: </strong>We report our experience with four male patients treated with Gore Viabahn balloon (Gore Medical, Flagstaff, AZ, USA) expandable stent-graft for different types of IA stenosis: three patients were symptomatic for vertebrobasilar insufficiency, while one patient was asymptomatic for cerebrovascular symptoms. The stent grafts were deployed using retrograde (N.=2) or antegrade approach (N.=2), aiming to cover the entire lesions length and to slightly protrude into the aortic arch. Post-dilatation was performed with a compliant balloon. One patient presented a tandem lesion (IA and right internal carotid artery) and after the stenting of the IA he was treated also with a carotid artery stenting during the same procedure.</p><p><strong>Results: </strong>Technical success was achieved in all patients. No perioperative or postoperative complications had been reported and the neurological disorders disappeared for the three symptomatic patients. After a mean clinical and radiological follow-up of 24±5 months, all the stents were patent and perfectly adapted to the vessels.</p><p><strong>Conclusions: </strong>This preliminary clinical experience shows that the use of the Gore Viabahn balloon (Gore Medical) expandable stent-graft seems safe and feasible for the treatment of the IA obstructive lesions, also in presence of irregular plaques and hostile anatomies for an endovascular treatment. Larger experiences and long-term data are mandatory.</p>","PeriodicalId":50245,"journal":{"name":"Journal of Cardiovascular Surgery","volume":" ","pages":"682-686"},"PeriodicalIF":1.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40376701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"TEVAR: future management based on today's scenarios.","authors":"Mario E Rios Ramirez","doi":"10.23736/S0021-9509.22.12492-4","DOIUrl":"https://doi.org/10.23736/S0021-9509.22.12492-4","url":null,"abstract":"","PeriodicalId":50245,"journal":{"name":"Journal of Cardiovascular Surgery","volume":"63 6","pages":"749-750"},"PeriodicalIF":1.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10370267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Arterial thoracic outlet syndrome: a 30-year experience in a high-volume referral center.","authors":"Lazar B Davidovic,&nbsp;Petar Zlatanovic,&nbsp;Marko Dragas,&nbsp;Igor Koncar,&nbsp;Mihajlo Micic,&nbsp;David Matejevic","doi":"10.23736/S0021-9509.22.12224-X","DOIUrl":"https://doi.org/10.23736/S0021-9509.22.12224-X","url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study was to assess the clinical presentation and contemporary management of arterial thoracic outlet syndrome (TOS) in high-volume referral center.</p><p><strong>Methods: </strong>We conducted a retrospective review of a prospectively maintained database of patients with TOS of any etiology between January 1^st 1990 and 2021. Supra-, or combined supra-/infraclavicular approaches have been used for decompression/vascular reconstructions. The group was divided into two equal time periods: period 1 (1990-2006, N.=27) and period 2 (2006-2021, N.=36).</p><p><strong>Results: </strong>Sixty-three consecutive patients underwent surgical treatment due to arterial TOS. Period 2 had more patients who were asymptomatic (N.=16, 44.4% vs. N.=0, 0%, P<0.001) and those presenting with critical hand ischemia (N.=12, 33.3% vs. N.=0, 0%, P=0.01), while acute limb ischemia was more common in period 1 (N.=16, 59.2% vs. N.=5, 13.9%, P<0.001). SA compression without lesion was more common in period 2 (N.=16, 44.4% vs. N.=0, 0%, P<0.001), while SA intimal damage with mural thrombus formation was more common in the period 1 (N.=12, 44.4% vs. N.=1, 2.7%, P<0.001). Decompression as an isolated procedure was performed in 25.4% (N.=16) of all asymptomatic patients, while combined decompressive and vascular procedure in 71.4% (N.=45) of patients. The most common postoperative complication was pneumothorax (N.=7, 11.1%).</p><p><strong>Conclusions: </strong>The supraclavicular approach with its modifications provides adequate decompression and allows also repair or reconstruction of the SA, as well as complete additional revascularization of the upper extremity without the need for further patient repositioning. While treatment methods and early outcomes have not changed significantly over time, there has been a trend towards different clinical and SA pathomorphological presentation.</p>","PeriodicalId":50245,"journal":{"name":"Journal of Cardiovascular Surgery","volume":" ","pages":"687-694"},"PeriodicalIF":1.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40359063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Propensity-matched comparison of right mini-thoracotomy versus median sternotomy for isolated mitral valve repair.","authors":"Sabet W Hashim,&nbsp;Sean R McMahon,&nbsp;Irena K Vaitkeviciute,&nbsp;Susan Collazo,&nbsp;Isabelle M Hashim,&nbsp;Deborah S Loya,&nbsp;Edmund T Takata,&nbsp;Jeff F Mather,&nbsp;Raymond G McKay","doi":"10.23736/S0021-9509.22.12397-9","DOIUrl":"https://doi.org/10.23736/S0021-9509.22.12397-9","url":null,"abstract":"<p><strong>Background: </strong>A right mini-thoracotomy (RT) versus median sternotomy (MS) approach for isolated mitral valve (MV) repair has been associated with less postoperative morbidity, shorter hospital stay, and faster functional recovery, but with consistently longer cross-clamp time and higher operative costs.</p><p><strong>Methods: </strong>We assessed the impact of a modified operative technique on outcomes in 158 RT versus 129 MS patients treated with myxomatous MV repair from 2016 through 2021. Propensity matching based upon the Society of Thoracic Surgeons Risk Score was used to compare 108 patients in each cohort.</p><p><strong>Results: </strong>Propensity-matched RT patients had reductions in total ventilation time (P=0.025), postoperative atrial fibrillation (P=0.019), and hospital length of stay (P<0.001). RT and MS patients had similar cross-clamp times (66.4±13.7 vs 64.8±16.0 minutes, P=0.414), with less overall leaflet resection (32.4% vs 57.4%, P<0.001) and fewer Gore-Tex NeoChords implanted per patient (1.7±0.7 vs 2.1±1.0, P=0.028) in the RT group. The two cohorts did not differ with respect to 30-day major surgical complications. No patient died and there was no difference between the two groups with respect to freedom from re-operation (98.2% vs 98.2%, P=0.800) at a mean follow-up of 21.4±18.5 months. Direct total hospital costs were lower for the RT group (P=0.018), with reductions in postoperative charges offsetting increased operating room costs.</p><p><strong>Conclusions: </strong>In this single-center study, the RT compared to the MS approach for myxomatous MV repair resulted in less postoperative morbidity and shorter hospital length of stay, with similar cross-clamp time, reduced total hospital costs, and comparable intermediate outcomes.</p>","PeriodicalId":50245,"journal":{"name":"Journal of Cardiovascular Surgery","volume":" ","pages":"724-733"},"PeriodicalIF":1.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40359064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Stroke and mortality rates after off-pump vs. pump-assisted/no-clamp coronary artery bypass grafting.","authors":"George V Letsou,&nbsp;Fadi I Musfee,&nbsp;Qianzi Zhang,&nbsp;Gabriel Loor,&nbsp;Andrew D Lee","doi":"10.23736/S0021-9509.22.12337-2","DOIUrl":"https://doi.org/10.23736/S0021-9509.22.12337-2","url":null,"abstract":"<p><strong>Background: </strong>Ascending aorta manipulation during on-pump coronary artery bypass grafting (CABG) surgery can release embolic matter and may cause stroke. Strategies for lowering the stroke rate associated with coronary artery bypass grafting surgery include off-pump surgery without cardiopulmonary bypass and pump-assisted surgery with minimal aortic manipulation (i.e., without aortic cross-clamping). We examined whether one approach is superior to the other in reducing stroke and perioperative mortality rates.</p><p><strong>Methods: </strong>We reviewed consecutive elective, urgent, and emergency off-pump/no-bypass and pump-assisted/no-clamp coronary artery bypass grafting procedures performed by a single surgeon at our institution from June 2011 through October 2017.</p><p><strong>Results: </strong>Of 570 patients analyzed, 395 (69.3%) underwent off-pump/no-bypass surgery, 43 (7.5%) underwent pump-assisted/no-clamp surgery, and 132 (23.2%) transitioned mid-procedure from off-pump/no-bypass to pump-assisted/no-clamp surgery. Patients who were >70 years old, were female, or had diabetes, cardiomegaly, or a history of myocardial infarction or congestive heart failure were more likely to undergo pump-assisted/no-clamp surgery or the combined technique. None of the pump-assisted/no-clamp patients had a stroke, versus 0.3% of the off-pump/no-bypass patients and 0.8% of the combination patients. Stroke and in-hospital mortality rates did not differ by technique.</p><p><strong>Conclusions: </strong>A hybrid strategy incorporating off-pump, pump-assisted, and combined off-pump/pump-assisted techniques achieved very low stroke rates in patients undergoing coronary revascularization. Perioperative mortality was similar for all three techniques. Avoiding aortic clamping may be crucial for decreasing CABG-related stroke rates. Off-pump/no-bypass surgery had no significant advantage over the pump-assisted/no-clamp or combined techniques in reducing the stroke rate after coronary artery bypass grafting surgery.</p>","PeriodicalId":50245,"journal":{"name":"Journal of Cardiovascular Surgery","volume":" ","pages":"742-748"},"PeriodicalIF":1.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40376703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of fluid balance and blood transfusion during extracorporeal circulation on outcome for acute type A aortic dissection surgery.","authors":"Jing Li,&nbsp;Andrea Stadlbauer,&nbsp;Anton Heller,&nbsp;Zhiyang Song,&nbsp;Walter Petermichl,&nbsp;Maik Foltan,&nbsp;Christof Schmid,&nbsp;Simon Schopka","doi":"10.23736/S0021-9509.22.12339-6","DOIUrl":"https://doi.org/10.23736/S0021-9509.22.12339-6","url":null,"abstract":"<p><strong>Background: </strong>In thoracic aortic surgery, fluid replacement and blood transfusion during extracorporeal circulation (ECC) are associated with increased coagulopathy, elevated inflammatory response, and end-organ dysfunction. The optimal strategy has not been established in this regard. The aim of this study was to evaluate the effect of the fluid balance during ECC in thoracic aortic dissection surgery on outcome.</p><p><strong>Methods: </strong>Between 2009 and 2020, 358 patients suffering from acute type A aortic dissection (ATAAD) underwent aortic surgery at our heart center. In-hospital mortality, major complications (postoperative stroke, respiratory failure, heart failure, acute renal failure), and follow-up mortality were assessed. Logistic regression analysis was used to identify whether fluid balance and blood transfusion during ECC were risk factors for occurring adverse events.</p><p><strong>Results: </strong>The in-hospital mortality amounted to 20.4%. Major complications included temporary neurologic deficit in 13.4%, permanent neurologic deficit in 6.1%, acute renal failure in 32.7%, prolonged ventilation for respiratory failure in 17.9%, and acute heart failure in 10.9% of cases. At a mean of 42 months after discharge of 285 survivors, follow-up mortality was 13.3%. Multivariate analysis revealed major complications as well as the risk of in-hospital and follow-up mortality to increase with fluid balance and blood transfusion during ECC.</p><p><strong>Conclusions: </strong>Fluid balance and blood transfusion during ECC present with predictive potential concerning the risk of postoperative adverse events.</p>","PeriodicalId":50245,"journal":{"name":"Journal of Cardiovascular Surgery","volume":" ","pages":"734-741"},"PeriodicalIF":1.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40661283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dealing with malignancy involving the inferior vena cava in the 21st century.","authors":"Marco Baia,&nbsp;David N Naumann,&nbsp;Chee S Wong,&nbsp;Fahad Mahmood,&nbsp;Alessandro Parente,&nbsp;Daniele Bissacco,&nbsp;Max Almond,&nbsp;Samuel J Ford,&nbsp;Fabio Tirotta,&nbsp;Anant Desai","doi":"10.23736/S0021-9509.22.12408-0","DOIUrl":"https://doi.org/10.23736/S0021-9509.22.12408-0","url":null,"abstract":"<p><strong>Introduction: </strong>Malignancies involving the inferior vena cava (IVC) have historically been considered not amendable to surgery. More recently, involvement of the IVC by neoplastic processes in the kidney, liver or in the retroperitoneum can be managed successfully.</p><p><strong>Evidence acquisition: </strong>In this systematic review we summarize the current evidence regarding the surgical management of the IVC in cases of involvement in neoplastic processes. Current literature was searched, and studies selected on the base of the PRISMA guidelines. Evidence was synthesized in narrative form due to heterogeneity of studies.</p><p><strong>Evidence synthesis: </strong>Renal cell carcinoma accounts for the greatest proportion of studied patients and can be managed with partial or complete vascular exclusion of the IVC, thrombectomy and direct closure or patch repair with good oncological prognosis. Hepatic malignancies or metastases may involve the IVC, and the joint expertise of hepatobiliary and vascular surgeons has developed various strategies, according to the location of tumor and the need to perform a complete vascular exclusion above the hepatic veins. In retroperitoneal lymph node dissection, the IVC can be excised en-block to guarantee better oncological margins. Also, in retroperitoneal sarcomas not arising from the IVC a vascular substitution may be required to improve the overall survival by clearing all the neoplastic cells in the retroperitoneum. Leiomyoma can have a challenging presentation with involvement of the IVC requiring either thrombectomy, partial or complete substitution, with good oncological outcomes.</p><p><strong>Conclusions: </strong>A multidisciplinary approach with specialist expertise is required when dealing with IVC involvement in surgical oncology. Multiple techniques and strategies are required to deliver the most efficient care and achieve the best possible overall survival. The main aim of these procedures must be the complete clearance of all neoplastic cells and achievement of a safe margin according to the perioperative treatment strategy.</p>","PeriodicalId":50245,"journal":{"name":"Journal of Cardiovascular Surgery","volume":" ","pages":"664-673"},"PeriodicalIF":1.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33511063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Primary malignancy of the inferior vena cava, a review of surgical treatments and outcomes.","authors":"Alessandra Borghi,&nbsp;Alessandra Scotto DI Uccio,&nbsp;Alessandro Gronchi","doi":"10.23736/S0021-9509.22.12418-3","DOIUrl":"https://doi.org/10.23736/S0021-9509.22.12418-3","url":null,"abstract":"<p><strong>Introduction: </strong>Primary malignancies of the inferior vena cava comprise a heterogeneous group of histologic types that generally have a poor prognosis. Their rarity limits the data available in literature. There is no doubt that surgery is the mainstay treatment, but several questions about the best surgical strategy and multidisciplinary approach remain. The present review covers the surgical technique including the various reconstructive modalities and the available evidence about treatments and outcomes.</p><p><strong>Evidence acquisition: </strong>From literature research, we identified 15 case series of patients with primary inferior vena cava tumors, who underwent surgery from 2000 onwards. Details on resection and reconstruction, focusing on both oncologic and surgical issues, were analyzed and summarized.</p><p><strong>Evidence synthesis: </strong>Inferior vena cava malignancies can be either primary or secondary. The main primary tumor is leiomyosarcoma, while retroperitoneal liposarcomas and renal carcinomas are the main causes of secondary invasion. The outcomes of primary inferior vena cava leiomyosarcoma are linked to its metastatic risk. However, long-term survivors do exist. The factors that determine the surgical strategy include extent of the disease, which segment is involved, additional organ resection needed, presence of collateral venous circulation. After a partial resection, the wall defect can be repaired primarily or by patch interposition. After a circumferential resection, the first decision is whether to reconstruct the vascular continuity. There are several options, including prosthetic (polytetrafluoroethylene and Dacron) or biological materials (from autologous venous grafts to cryopreserved aortic grafts).</p><p><strong>Conclusions: </strong>Tumors involving inferior vena cava are rare and challenging. A specific expertise is required to select the most appropriate surgical resection and reconstruction for the single patients in order to maximize the chance of cure alongside the quality of life.</p>","PeriodicalId":50245,"journal":{"name":"Journal of Cardiovascular Surgery","volume":" ","pages":"649-663"},"PeriodicalIF":1.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33511064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Interventions for superior vena cava syndrome.","authors":"Indrani Sen,&nbsp;Manju Kalra,&nbsp;Peter Gloviczki","doi":"10.23736/S0021-9509.22.12448-1","DOIUrl":"https://doi.org/10.23736/S0021-9509.22.12448-1","url":null,"abstract":"<p><p>Superior vena cava (SVC) syndrome refers to the clinical manifestations of cerebral venous hypertension secondary to obstruction of the SVC and/or the innominate veins. The most common cause of SVC syndrome is malignancy like small cell lung cancer and non-Hodgkin lymphoma, but there is an increasing trend of benign etiologies secondary to thrombosis due to central lines/ pacemakers or mediastinal fibrosis. Supportive measures include head elevation, diuresis, supplemental oxygen, and steroids. Thrombolysis with or without endovenous stenting is required emergently in those with airway compromise or symptoms secondary to cerebral edema. Definitive treatment in those with malignancy is multidisciplinary; this requires radiotherapy, chemotherapy, SVC stenting, oncologic surgery and SVC bypass or reconstruction. Endovascular treatment is the primary modality for palliation in malignancy and in those with benign etiology. Surgery is reserved for those who have failed or are unsuitable for endovascular treatment. In patients with benign disease endovenous stenting and open surgery provide excellent symptom relief and are safe and effective.</p>","PeriodicalId":50245,"journal":{"name":"Journal of Cardiovascular Surgery","volume":" ","pages":"674-681"},"PeriodicalIF":1.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35209928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Trends and treatments in vena cava disease: advancements, possibilities and perspectives.","authors":"Daniele Bissacco,&nbsp;Renato Casana","doi":"10.23736/S0021-9509.22.12520-6","DOIUrl":"https://doi.org/10.23736/S0021-9509.22.12520-6","url":null,"abstract":"","PeriodicalId":50245,"journal":{"name":"Journal of Cardiovascular Surgery","volume":"63 6","pages":"647-648"},"PeriodicalIF":1.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10370266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}